Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Roxadustat in Subjects With Different Degrees of Renal Function
NCT02965040Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of roxadustat in anemia of chronic kidney disease (CKD-A) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Maximum Plasma Concentration, Area Under the Concentration-Time Curve from Time Zero to Infinity and 7 more. Started Dec 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02965040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965040.